Literature DB >> 16356670

A comparative in vitro assessment of the drug release performance of pH-responsive polymers for ileo-colonic delivery.

Valentine C Ibekwe1, Hala M Fadda, Gary E Parsons, Abdul W Basit.   

Abstract

The aim of this study was to investigate the in vitro dissolution characteristics of pH-responsive polymers in a variety of simulated fluids. Prednisolone tablets were fabricated and coated with the following polymer systems: Eudragit S (organic solution), Eudragit S (aqueous dispersion), Eudragit FS (aqueous dispersion) and Eudragit P4135 (organic solution). Dissolution tests were conducted using a pH change method whereby tablets were transferred from acid to buffer. Three different buffer media were investigated: two compendial phosphate buffers (pH range 6.8-7.4) and a physiological buffer solution (Hanks buffer) with very similar ionic composition to intestinal fluid (pH 7.4). There was considerable drug release from tablets coated with Eudragit P4135 in acid, prompting discontinuation of further investigations of this polymer. Eudragit S (organic solution), Eudragit S (aqueous dispersion) and Eudragit FS on the other hand prevented drug release in acid, though subsequent drug release in the buffer media was found to be influenced by the duration of tablet exposure to acid. At pH 7.4 drug release rate from the polymer coated tablets was similar in the two compendial media, however in the physiological buffer, they were found to differ in the following order: Eudragit S (aqueous dispersion)>Eudragit FS>Eudragit S (organic solution). The results indicate that the tablets coated with the newer Eudragit FS polymer would be more appropriate for drug delivery to the ileo-colonic region in comparison to the more established Eudragit S. More importantly, however, dissolution in the physiological buffer was found to be markedly slower for all the coated tablets than in the two compendial buffers, a result akin to reported slower dissolution of enteric coated tablets in vivo. There is therefore the need to adequately simulate the ionic composition of the intestinal fluid in the dissolution media.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16356670     DOI: 10.1016/j.ijpharm.2005.10.038

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  17 in total

1.  Once daily, high-dose mesalazine controlled-release tablet for colonic delivery: optimization of formulation variables using Box-Behnken design.

Authors:  Ahmed Abd Elbary; Ahmed A Aboelwafa; Ibrahim M Al Sharabi
Journal:  AAPS PharmSciTech       Date:  2011-10-29       Impact factor: 3.246

2.  Compression-Coated Tablet for Colon Targeting: Impact of Coating and Core Materials on Drug Release.

Authors:  Siddhartha Maity; Biswanath Sa
Journal:  AAPS PharmSciTech       Date:  2015-08-14       Impact factor: 3.246

3.  Colon specific delivery of indomethacin: effect of incorporating pH sensitive polymers in xanthan gum matrix bases.

Authors:  Laila F A Asghar; Chetan B Chure; Sajeev Chandran
Journal:  AAPS PharmSciTech       Date:  2009-04-21       Impact factor: 3.246

4.  Meal-induced acceleration of tablet transit through the human small intestine.

Authors:  Hala M Fadda; Emma L McConnell; Michael D Short; Abdul W Basit
Journal:  Pharm Res       Date:  2008-11-04       Impact factor: 4.200

5.  Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release systems.

Authors:  Valentine C Ibekwe; Hala M Fadda; Emma L McConnell; Mandeep K Khela; David F Evans; Abdul W Basit
Journal:  Pharm Res       Date:  2008-05-09       Impact factor: 4.200

6.  Multivariate data analysis of factors affecting the in vitro dissolution rate and the apparent solubility for a model basic drug substance in aqueous media.

Authors:  Anita Maria Persson; Curt Pettersson; Josefin Rosén
Journal:  Pharm Res       Date:  2010-03-27       Impact factor: 4.200

Review 7.  Advances in colonic drug delivery.

Authors:  Abdul W Basit
Journal:  Drugs       Date:  2005       Impact factor: 9.546

8.  Proof-of-concept study on the suitability of 13C-urea as a marker substance for assessment of in vivo behaviour of oral colon-targeted dosage forms.

Authors:  R C A Schellekens; G G Olsder; S M C H Langenberg; T Boer; H J Woerdenbag; H W Frijlink; J G W Kosterink; F Stellaard
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

9.  Coatings of Eudragit® RL and L-55 Blends: Investigations on the Drug Release Mechanism.

Authors:  Robert Wulff; Claudia S Leopold
Journal:  AAPS PharmSciTech       Date:  2015-08-12       Impact factor: 3.246

10.  Chitosan-carboxymethyl tamarind kernel powder interpolymer complexation: investigations for colon drug delivery.

Authors:  Gurpreet Kaur; Subheet Jain; Ashok K Tiwary
Journal:  Sci Pharm       Date:  2009-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.